Overall, the open-label phase 1/2 study is assessing the safety and anti-tumor activity with INKmune across 3 dose levels. “The key here is I don’t believe that testosterone increases the risk of ...

Prostate cancer incidence and mortality are increasing, with over 313,000 diagnoses and 35,000 deaths projected for 2025. Screening practices, influenced by the US Preventive Services Task Force, have ...

"It really remains to be seen whether we can expand this to care for other types of urological inpatients," says Timothy D. Lyon, MD. In this video, Timothy D. Lyon, MD, discusses the Urology Practice ...

"If a practice has determined in writing that there are insurers whose policies advised that they will not accept this code, it seems reasonable not to report that code to that insurer even when ...

"The three-year durability data from this study further validate the potential of JELMYTO in providing long-term disease control for patients with low-grade upper tract urothelial cancer,” says ...

"There are actually no data to support that 1 neuromodulation is better than another based on disease severity, and this is based on the systematic review done for the OAB guideline," says Anne ...

MiR-371a-3p demonstrates high sensitivity and specificity, outperforming traditional tumor markers in testicular cancer diagnosis and monitoring. MiR-371a-3p shows potential in early relapse detection ...

WNT9B gene mutations significantly increase prostate cancer risk, with a 2- to 12-fold elevation observed across multiple studies. Specific variants, WNT9B E152K and Q47R, show significant ...

"Physician scored GU toxicity grade 2 or greater at 2 years was 51% with the CT-guided and 27% with the MRI-guided," says Amar U. Kishan, MD. In this video, Amar U. Kishan, MD, shares the initial and ...

Panelists discuss how low-risk non–muscle-invasive bladder cancer (NMIBC) requires transurethral resection of bladder tumor (TURBT) with surveillance. Intermediate-risk disease needs adjuvant ...

“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD.

Urologists emphasized the importance of AUA guidelines, patient context, and clinical judgment in managing low-grade UTUC. Challenges in diagnosis and treatment include obtaining adequate biopsies and ...